TY  - CONF

T1  - 2530 Baseline characteristics, number of radium-223 (Ra-223) injections, and overall survival (OS) in US Expanded Access Program (EAP) and ALSYMPCA

JO  - European Journal of Cancer

PY  - 2015/09/01

AU  - Sartor O

AU  - Coleman RE

AU  - Morris MJ

AU  - Nilsson S

AU  - Shore N

AU  - Sweeney C

AU  - Vogelzang NJ

AU  - Petrenciuc O

AU  - Gratt J

AU  - Parker C

ED  - 

DO  - DOI: 10.1016/s0959-8049(16)31349-1

PB  - Elsevier BV

VL  - 51

SP  - S484

EP  - S485

Y2  - 2025/10/10

ER  -